Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis-Reference-Cited by-同舟云学术

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis

Published:2010-11-16 Issue:6 Volume:120 Page:719-729
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Metellus Philippe,Coulibaly Bema,Colin Carole,de Paula Andre Maues,Vasiljevic Alexandre,Taieb David,Barlier Anne,Boisselier Blandine,Mokhtari Karima,Wang Xiao Wei,Loundou Anderson,Chapon Frederique,Pineau Sandrine,L’Houcine Ouafik ,Chinot Olivier,Figarella-Branger Dominique

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00401-010-0777-8.pdf

Reference53 articles.

1. Anker L, Ohgaki H, Ludeke BI, Herrmann HD, Kleihues P, Westphal M (1993) p53 protein accumulation and gene mutations in human glioma cell lines. Int J Cancer 55:982–987

2. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116:597–602

3. Bauman G, Fisher B, Watling C, Cairncross JG, Macdonald D (2009) Adult supratentorial low-grade glioma: long-term experience at a single institution. Int J Radiat Oncol Biol Phys 75:1401–1407

4. Bleeker FE, Lamba S, Leenstra S et al (2009) IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 30:7–11

5. Bouvier C, Roll P, Quilichini B et al (2004) Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies. J Neurooncol 68:141–149

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship Between the Molecular Phenotypes of Brain Gliomas and the Imaging Features and Sensitivity of Radiotherapy and Chemotherapy;Clinical Oncology;2024-09

2. Geriatric grade 2 and 3 gliomas: A national cancer database analysis of demographics, treatment utilization, and survival;Journal of Clinical Neuroscience;2024-09

3. Connectomic insights into the impact of 1p/19q co-deletion in dominant hemisphere insular glioma patients;Frontiers in Neuroscience;2024-07-29

4. Brainstem Gliomas With Isocitrate Dehydrogenase Mutation: Natural History, Clinical-Radiological Features, Management Strategy, and Long-Term Outcome;Neurosurgery;2024-06-11

5. Volumetric Response and Survival of Patients With Bulky IDH-Mutated Grade 3 Glioma Managed With FET-FDG–Guided Integrated Boost IMRT;Clinical Oncology;2024-06